Market intelligence, trend analysis and forecasts for the Pharma and Healthcare industries across the regions

South Africa

South Africa Articles

Industry

Interactions and acquisitions between Aspen Pharmacare and GlaxoSmithKline (GSK) have resulted in Aspen continually expanding its international presence. BMI believes increasing its... 2013-06-20


Industry

Poor supply chain management of anti-retroviral (ARV) drugs in South Africa is a substantial obstacle to tackling the HIV/AIDS burden. South Africa currently has the highest HIV/AIDS... 2013-06-19


Industry

BMI View: Consumption and abuse control of codeine-containing medicines is most effective and best-regulated through a 'prescription-only' policy, forcing consumers to consult with... 2013-05-31


More ARTICLES

Industry

BMI View: Increasing competition in the bid to partially or completely buy out South African drugmaker Adcock Ingram, as well as strong revenue growth outlooks for the company in 2013... 2013-05-14


Industry

BMI View: The South African government's move to limit market exclusivity periods on patented medicines will be positive for the local economy. It will drive domestic production of... 2013-04-25


Industry

BMI View: In light of swifter global uptake of generic medicines and heightened competition in the generic drug sector, acquisitions will become more popular as a growth strategy for... 2013-04-19


Industry

BMI View: South Africa is the best investment opportunity for multinational drugmakers seeking to enter the African market. The country currently boasts the largest medicines market... 2013-04-02


Industry

BMI View: Internal disruptions to the company's senior management panel, in addition to poor cost- and expense-containment capabilities, are making Cipla Medpro increasingly susceptible... 2013-03-28

Middle East & Africa InsightMiddle East & Africa Channels Middle East & Africa Countries